D-0624-2024 Class II Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0624-2024 was initiated by Eugia US LLC on Jul 26, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: Complaint received of a glass particle in the vial. The recall status is ongoing. Affected quantity: 17136 vials.

Recall details

Product Type
Drugs
Report Date
Aug 7, 2024
Initiation Date
Jul 26, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17136 vials

Product description

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Reason for recall

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Distribution pattern

Nationwide in the USA

Code information

Lot #: CPR230029A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0624-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0624-2024. Report a data issue: hello@regdatalab.com.